These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The importance of early treatment for the prognosis of rheumatoid arthritis. Kyburz D; Finckh A Swiss Med Wkly; 2013; 143():w13865. PubMed ID: 24089023 [TBL] [Abstract][Full Text] [Related]
6. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622 [TBL] [Abstract][Full Text] [Related]
7. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766 [TBL] [Abstract][Full Text] [Related]
8. [Modern therapy of rheumatoid arthritis. Joint destruction can be delayed]. Neumaier J MMW Fortschr Med; 2008 Apr; 150(14):14. PubMed ID: 18488571 [No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of rheumatoid arthritis]. Krüger K Dtsch Med Wochenschr; 2014 Sep; 139(37):1823-34. PubMed ID: 25180998 [TBL] [Abstract][Full Text] [Related]
11. Biologic therapy for early rheumatoid arthritis: the latest evidence. Castro-Rueda H; Kavanaugh A Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524 [TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis. Castrejón I; Gibson KA; Pincus T Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037 [TBL] [Abstract][Full Text] [Related]
14. Management of early rheumatoid arthritis. Suresh E J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697 [TBL] [Abstract][Full Text] [Related]
15. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T; Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of rheumatoid arthritis and its comorbidities]. Krüger K Internist (Berl); 2018 Apr; 59(4):341-351. PubMed ID: 29508003 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846 [TBL] [Abstract][Full Text] [Related]